OREM, Utah, Sept. 24, 2014 (GLOBE NEWSWIRE) -- ActiveCare, Inc. (OTCBB:ACAR), a leader in diabetes management and wellness services for self-insured employers nationwide, today announced the appointment of Mr. Michael Z. Jones as President and interim Chief Executive Officer effective October 1, 2014. Mr. Jones will replace Mr. David Derrick who is stepping down for personal reasons.
"On behalf of the board of directors and the entire executive management team I would like to thank David for his experience, innovation and leadership in building ActiveCare into a leader in the diabetes marketplace," commented Mr. Jones. "I look forward to working with the entire team to focus our efforts on expanding our sales and marketing activity to rapidly accelerate our revenue growth. We are extremely excited about our future in the diabetes market. Through the development of our existing contracts and key partners we anticipate achieving $11 million in revenue over the next 12 months."
Mr. Jones has been a founder and executive in several of the technology industry's fastest growing companies. He founded Interactive Care in 2007, filing several patents in the field of video collaboration as a tool for the delivery of medical care. As Executive Vice President of Sales and Marketing at RemedyMD, Michael led the company's efforts in the utilization of informatics technologies for the treatment of obesity and diabetes. While Executive Vice President of Sales and Marketing at iBahn (formerly STSN), the company was recognized in consecutive years by Deloitte & Touche and Inc. Magazine for its explosive growth, expanding from $29M to over $120M in annual sales over a three-year period. Prior to iBahn, Mr. Jones led numerous sales and operations organizations at Iomega Corporation during a period of unprecedented growth, exponentially expanding its distribution, customer support, production and logistics capacities. Michael has also had key roles in domestic and international senior sales leadership roles at Siebel Systems, Silicon Graphics and Oracle. A published author and contributor to periodicals and industry publications, Michael graduated from the University of Utah with a degree in English.
ActiveCare, Inc. provides proprietary diabetes management and wellness solutions providing increased visibility to its members' health, enabling real-time care for members, and improving clinical and financial outcomes. Utilizing state-of-the-art blood glucose meters with embedded cellular technology, trained CareSpecialists intervene in real-time and provide members with the support needed to control their disease 24 hours a day, seven days a week. ActiveCare's solution is revolutionizing the way employers, individuals and their health plans monitor and manage chronic diseases. To learn more about ActiveCare please visit www.activecare.com.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including global economic conditions generally, regulatory uncertainty and economic pressure on the healthcare industry in particular, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with assimilating our recent acquisitions. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.
CONTACT: Company Contact: Bryan Dalton, Director of Market Strategies ActiveCare, Inc. (877) 862-5545 Investor Relations: Capital Markets Group, LLC (212) 398-3486
Released September 24, 2014